---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-015212"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T03:05:31.429940+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Onconetix to acquire Realbotix in reverse merger; Realbotix holders to own 75-90%

## Summary
- Onconetix issues shares to Realbotix seller such that seller owns 75%–90% of fully diluted shares based on Net Cash at closing.
- Closing requires Onconetix to have at least $12.5M Net Cash and enter a $125M equity line of credit.
- Post-closing board: 5 directors with 4 designated by Realbotix and 1 by Onconetix.
- Realbotix is an AI humanoid robotics company with U.S. manufacturing, proprietary AI, and multilingual robots.
- Termination fee: $500k plus expenses (capped at $500k); additional $1.5M if Buyer Superior Proposal closes.

## SEC filing metadata
- accession: 0001213900-26-015212
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390026015212/0001213900-26-015212-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390026015212/ea0276704-8k425_onconet.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-015212
- JSON: https://secwatch.observer/filing/0001213900-26-015212.json
- Plain text: https://secwatch.observer/filing/0001213900-26-015212.txt

## Key facts
- Material Agreements
  Onconetix, Inc. entered into Share Exchange Agreement with Realbotix Corp., Simulacra Corporation, and Realbotix, LLC (effective 2026-02-11).
  - Action: entry
  - Agreement: merger
  - Counterparty: Realbotix Corp., Simulacra Corporation, and Realbotix, LLC
  - Effective: 2026-02-11
  source text: On February 11, 2026, Onconetix, Inc, a Delaware corporation (“ Onconetix ” or “ Buyer ”), entered into a Share Exchange Agreement (the “ Share Exchange Agreement ”), by and among (i) Onconetix, (ii) Realbotix Corp., a company existing under the laws of the Province of Ontario (“ Parent ”), (iii) Simulacra Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (the “ Seller ”) and (iv) Realbotix, LLC, a Delaware limited liability company and wholly owned subsidiary of the Seller (the “ Company ” or “ Realbotix ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390026015212/0001213900-26-015212-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.